Shuang Qiao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Induced Apoptosis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Meng He, Yongxiang Liu, Song Chen, Haijing Deng, Cheng Feng, Shuang Qiao, Qifeng Chen, Yue Hu, Huiming Chen, Xun Wang, Xiongying Jiang, Xiaojun Xia, Ming Zhao, Ning Lyu
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Meng He, Yongxiang Liu, Song Chen, Haijing Deng, Cheng Feng, Shuang Qiao, Qifeng Chen, Yue Hu, Huiming Chen, Xun Wang, Xiongying Jiang, Xiaojun Xia, Ming Zhao, Ning Lyu
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Meng He, Yongxiang Liu, Song Chen, Haijing Deng, Cheng Feng, Shuang Qiao, Qifeng Chen, Yue Hu, Huiming Chen, Xun Wang, Xiongying Jiang, Xiaojun Xia, Ming Zhao, Ning Lyu
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Shuang Qiao, Wenhua Lu, Christophe Glorieux, Jiangjiang Li, Peiting Zeng, Ning Meng, Huiqin Zhang, Shijun Wen, Peng Huang
Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer. Oncogene 40 (39) (2021)